These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8198467)
21. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. Kyndt X; Reumaux D; Bridoux F; Tribout B; Bataille P; Hachulla E; Hatron PY; Duthilleul P; Vanhille P Am J Med; 1999 May; 106(5):527-33. PubMed ID: 10335724 [TBL] [Abstract][Full Text] [Related]
22. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population. Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885 [TBL] [Abstract][Full Text] [Related]
23. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705 [TBL] [Abstract][Full Text] [Related]
24. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement. Dringenberg C; Apenberg S; Andrassy K Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653 [TBL] [Abstract][Full Text] [Related]
25. A case report of mixed P- and C-ANCA positive patients with pauci-immune crescentic glomerulonephritis. Shimizu E; Nakabayashi I; Kubota T; Suzuki Y; Shimizu J; Ishida A; Yoshida M; Yoshizawa N Clin Nephrol; 1995 Oct; 44(4):266-70. PubMed ID: 8575128 [TBL] [Abstract][Full Text] [Related]
33. Value of tests for antineutrophil cytoplasmic autoantibodies in the diagnosis and treatment of vasculitis. Niles JL Curr Opin Rheumatol; 1993 Jan; 5(1):18-24. PubMed ID: 8435285 [TBL] [Abstract][Full Text] [Related]
34. Thoughts about the classification of small vessel vasculitis. Falk RJ; Jennette JC J Nephrol; 2004; 17 Suppl 8():S3-9. PubMed ID: 15599883 [TBL] [Abstract][Full Text] [Related]
35. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations. Bosch X; Font J; Mirapeix E; Revert L; Urbano-Márquez A; Ingelmo M Adv Exp Med Biol; 1993; 336():281-6. PubMed ID: 8296618 [TBL] [Abstract][Full Text] [Related]
36. An association between ANCA positive renal disease and malignancy. Edgar JD; Rooney DP; McNamee P; McNeill TA Clin Nephrol; 1993 Jul; 40(1):22-5. PubMed ID: 8358871 [TBL] [Abstract][Full Text] [Related]
37. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Gaudin PB; Askin FB; Falk RJ; Jennette JC Am J Clin Pathol; 1995 Jul; 104(1):7-16. PubMed ID: 7611186 [TBL] [Abstract][Full Text] [Related]
38. Use of anti-neutrophil cytoplasmic antibody assay to distinguish between vasculitic disease activity and complications of cytotoxic therapy. Markey BA; Warren JS Am J Clin Pathol; 1994 Nov; 102(5):589-94. PubMed ID: 7942622 [TBL] [Abstract][Full Text] [Related]
39. [Anti-neutrophil cytoplasmic antibodies (ANCA): major progress in the diagnosis of vasculitis]. Goldman M; Servais C; Lambermont M; Tielemans C; Lambrechts A; Mascart-Lemone F; Dupont E Rev Med Brux; 1992 Nov; 13(9):333-6. PubMed ID: 1361072 [TBL] [Abstract][Full Text] [Related]